FindTrial
Sign In

Effect of yerba mate extract consumption on anthropometric parameters, body composition, and blood markers of inflammation, glycemic profile, and lipid profile in overweight individuals

Yerba mate extract (Ilex paraguarensis): effect of ingestion on anthropometric parameters, body composition, inflammatory markers, glycemic profile, and lipid profile in overweight individuals: a randomized, placebo-controlled, crossover, and triple-blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9d29wpj
Enrollment
Unknown
Registered
2025-02-14
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight.

Interventions

This study is characterized as a randomized, placebo-controlled, crossover, triple-blind clinical trial with a 60-day dietary intervention. Thirty-six participants will be randomized to receive yerba
B01.875.800.575.912.250.084.500.750

Sponsors

Universidade Federal de Santa Catarina - UFSC
Lead Sponsor
Universidade Federal de Santa Catarina - UFSC
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals over the age of 18; Body Mass Index (BMI) greater than or equal to 24.99 kg/m²; both sexes

Exclusion criteria

Exclusion criteria: Individuals with a Body Mass Index (BMI) greater than or equal to 24.99 kg/m²; significant weight variation (more than 10%) in the last 3 months; use of anti-inflammatory medications; pregnancy or breastfeeding; allergies or hypersensitivity to any of the ingredients of the interventions; smoking; alcoholism; intense physical activity

Design outcomes

Primary

MeasureTime frame
To assess body composition using dual-energy X-ray absorptiometry (DXA) computed densitometry at baseline and 30 days after consuming each intervention (yerba mate extract and placebo)—

Secondary

MeasureTime frame
Secondary outcomes are not expected.—

Countries

Brazil

Contacts

Public ContactPatricia Di Pietro

Universidade Federal de Santa Catarina - UFSC

patricia.di.pietro@ufsc.br+554799635939

Outcome results

None listed

Source: REBEC (via WHO ICTRP)